Compounding Pharmacy Compliance 2025, June 2-3, 2025, Boston, MA
Prompt Praxis Labs is sponsoring and attending the Compounding Pharmacy Compliance 2024, June 18-19, in Boston, MA.
Prompt Praxis Laboratories provides a full range of rapid, analytical laboratory testing and lab support services focusing on pharmaceutical products and compounded sterile or nonsterile preparations.
Our analytical testing lab support activities span three major industries:
The scope and breadth of the lab services we offer are extensive, and we anticipate phasing in specialty capabilities based upon the growth of our client base and diversification of development activities. Lab services in support of other dosage forms may be included in various expansion phases of the laboratory.
Prompt Praxis Labs is sponsoring and attending the Compounding Pharmacy Compliance 2024, June 18-19, in Boston, MA.
Drug diversion testing is a crucial aspect of healthcare that ensures patient safety and the proper use of controlled substances. Drug diversion refers to the illegal transfer of prescription drugs from the legal supply chain to the illegal market.
Prompt Praxis Labs helps you in designing, developing, implementing and managing an effective, safe and secure Analytical Testing Program for a Pharma Product.
We offer Ready To Analyze® Test Methods for analyzing a product’s strength, quality, purity, potency, and identity. We also provide services for analytical characterization, bioanalytical services, method development and validation, as well as method transfer and assistance.
Creating unrivaled capacity for timely results.
Prompt Praxis Laboratories, analytical testing labs, provide a full range of rapid testing and support services focusing on pharmaceutical products and compounded sterile or nonsterile preparations.
Complete the form below, and we will be in touch shortly.
Prompt Praxis Laboratories, LLC, founded in 2011, is a women-owned fully-integrated analytical and microbiological testing lab powered with the current information technology to facilitate rapid drug development.
FDA Establishment Identifier:
3009381492
GDUFA Self-Identified
Illinois DEA:
(Analytical Laboratory, Schedules II-V)
097.001930
Federal DEA:
(Analytical Laboratory, Schedules II-V)
RM0458097
Phone
Locations
50 Lakeview Parkway, Suite 123
Vernon Hills, IL 60061-1590
150 N Fairway Drive, Suites 148-154
Vernon Hills, IL 60061-1860